Seneca Growth Capital VCT PLC (HYG) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.005x

Based on the latest financial reports, Seneca Growth Capital VCT PLC (HYG) has a cash flow conversion efficiency ratio of -0.005x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-70.00K ≈ $-8.52 USD) by net assets (GBX13.94 Million ≈ $1.70K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Seneca Growth Capital VCT PLC market cap and net worth for the company's overall valuation and market capitalisation.

Seneca Growth Capital VCT PLC - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Seneca Growth Capital VCT PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Seneca Growth Capital VCT PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seneca Growth Capital VCT PLC ranked by their cash flow conversion efficiency. Explore Seneca Growth Capital VCT PLC cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Micromobility.com Inc.
NASDAQ:MCOM
0.010x
Gimat Magazacilik Sanayi ve Ticaret AS
IS:GMTAS
-0.001x
Zenova Group PLC
LSE:ZED
-0.142x
MIRIS HOLDING AB O.N.
F:9W4
N/A
Ordinary Fully Paid Deferred Settlement
AU:HRZDB
-0.180x
PipeHawk plc
LSE:PIP
0.022x
Sorted Group Holdings Plc
LSE:SORT
1.476x
musicMagpie PLC
LSE:MMAG
0.302x

Annual Cash Flow Conversion Efficiency for Seneca Growth Capital VCT PLC (2002–2024)

The table below shows the annual cash flow conversion efficiency of Seneca Growth Capital VCT PLC from 2002 to 2024. View HYG live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX13.94 Million
≈ $1.70K
GBX-257.00K
≈ $-31.27
-0.018x +32.14%
2023-12-31 GBX16.89 Million
≈ $2.06K
GBX-459.00K
≈ $-55.85
-0.027x -2.42%
2022-12-31 GBX18.13 Million
≈ $2.21K
GBX-481.00K
≈ $-58.52
-0.027x -63.63%
2021-12-31 GBX17.76 Million
≈ $2.16K
GBX-288.00K
≈ $-35.04
-0.016x +9.99%
2020-12-31 GBX10.77 Million
≈ $1.31K
GBX-194.00K
≈ $-23.60
-0.018x -9.44%
2019-12-31 GBX8.38 Million
≈ $1.02K
GBX-138.00K
≈ $-16.79
-0.016x -44.12%
2018-12-31 GBX9.28 Million
≈ $1.13K
GBX-106.00K
≈ $-12.90
-0.011x +45.72%
2017-12-31 GBX5.18 Million
≈ $630.26
GBX-109.00K
≈ $-13.26
-0.021x +11.57%
2016-12-31 GBX5.55 Million
≈ $674.91
GBX-132.00K
≈ $-16.06
-0.024x +4.05%
2015-12-31 GBX6.13 Million
≈ $745.72
GBX-152.00K
≈ $-18.49
-0.025x -133.18%
2014-12-31 GBX7.33 Million
≈ $892.34
GBX-78.00K
≈ $-9.49
-0.011x +59.38%
2013-12-31 GBX7.83 Million
≈ $952.56
GBX-205.00K
≈ $-24.94
-0.026x -60.01%
2012-12-31 GBX9.59 Million
≈ $1.17K
GBX-157.00K
≈ $-19.10
-0.016x -141.15%
2011-12-31 GBX5.73 Million
≈ $697.54
GBX228.00K
≈ $27.74
0.040x +159.77%
2010-12-31 GBX6.28 Million
≈ $764.34
GBX-418.00K
≈ $-50.86
-0.067x -2445.99%
2009-12-31 GBX7.40 Million
≈ $900.85
GBX21.00K
≈ $2.56
0.003x +108.45%
2008-12-31 GBX5.16 Million
≈ $627.21
GBX-173.00K
≈ $-21.05
-0.034x -26.76%
2007-12-31 GBX4.61 Million
≈ $560.66
GBX-122.00K
≈ $-14.84
-0.026x +70.85%
2006-12-31 GBX4.29 Million
≈ $522.46
GBX-390.00K
≈ $-47.45
-0.091x -142.16%
2005-12-31 GBX5.68 Million
≈ $690.97
GBX-213.00K
≈ $-25.92
-0.038x -152.01%
2004-12-31 GBX6.29 Million
≈ $765.92
GBX454.00K
≈ $55.24
0.072x +489.40%
2003-12-31 GBX6.91 Million
≈ $840.87
GBX-128.00K
≈ $-15.57
-0.019x -135.08%
2002-12-31 GBX6.73 Million
≈ $818.48
GBX-53.00K
≈ $-6.45
-0.008x --

About Seneca Growth Capital VCT PLC

LSE:HYG UK Asset Management
Market Cap
$8.89K
GBX73.04 Million GBX
Market Cap Rank
#31829 Global
#1299 in UK
Share Price
GBX9.00
Change (1 day)
+28.57%
52-Week Range
GBX0.06 - GBX9.00
All Time High
GBX33.12
About

Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gro… Read more